Effects of Lipopolysaccharide-Binding Protein (LBP) Single Nucleotide Polymorphism (SNP) in Infections, Inflammatory Diseases, Metabolic Disorders and Cancers

Inflammation, which is induced by the immune response, is recognized as the driving factor in many diseases, including infections and inflammatory diseases, metabolic disorders and cancers. Genetic variations in pivotal genes associated with the immune response, particularly single nucleotide polymo...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 12; p. 681810
Main Authors Meng, Leilei, Song, Zichen, Liu, Anding, Dahmen, Uta, Yang, Xiao, Fang, Haoshu
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 06.07.2021
Subjects
Online AccessGet full text
ISSN1664-3224
1664-3224
DOI10.3389/fimmu.2021.681810

Cover

More Information
Summary:Inflammation, which is induced by the immune response, is recognized as the driving factor in many diseases, including infections and inflammatory diseases, metabolic disorders and cancers. Genetic variations in pivotal genes associated with the immune response, particularly single nucleotide polymorphisms (SNPs), may account for predisposition and clinical outcome of diseases. Lipopolysaccharide (LPS)-binding protein (LBP) functions as an enhancer of the host response to LPS, the main component of the outer membrane of gram-native bacteria. Given the crucial role of LBP in inflammation, we will review the impact of SNPs in the LBP gene on infections and inflammatory diseases, metabolic disorders and cancers.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Edited by: Anna Di Nardo, University of California, San Diego, United States
Reviewed by: Maurizio Zanetti, University of California, San Diego, United States; Changjiang Dong, University of East Anglia, United Kingdom
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2021.681810